Corbus Pharmaceuticals Holdings, Inc. Diluted Shares Outstanding (Weighted Average)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Diluted Shares Outstanding (Weighted Average) of 19.41 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 19.41M shares, a 58.55% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 18.71M shares, a 53.31% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 16.52M shares, a 35.51% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 12.31M shares, a 2.44% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 13.32M shares, a 22.00% increase from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 10.92M shares, a 152.23% increase from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 4.33M shares, a 3.76% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 4.17M shares, a 1.85% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 19.41M shares 10-Q · filed 2026-08-06 | 19.06M shares 10-Q · filed 2026-08-06 | 18.21M shares derived: average of 3 quarters · filed 2026-08-06 | 16.73M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | 18.71M shares 10-Q · filed 2026-05-12 | 17.61M shares derived: average of 2 quarters · filed 2026-05-12 | 15.84M shares derived: average of 3 quarters · filed 2026-05-12 | 14.94M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | 16.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 14.41M shares derived: average of 2 quarters · filed 2026-03-09 | 13.69M shares derived: average of 3 quarters · filed 2026-08-06 | 13.32M shares 10-K · filed 2026-03-09 | ||
| 2025-09-30 | 12.31M shares 10-Q · filed 2025-11-12 | 12.27M shares derived: average of 2 quarters · filed 2026-08-06 | 12.25M shares 10-Q · filed 2025-11-12 | 12.23M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | 12.24M shares 10-Q · filed 2026-08-06 | 12.22M shares 10-Q · filed 2026-08-06 | 12.21M shares derived: average of 3 quarters · filed 2026-08-06 | 12.16M shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 12.20M shares 10-Q · filed 2026-05-12 | 12.20M shares derived: average of 2 quarters · filed 2026-05-12 | 12.14M shares derived: average of 3 quarters · filed 2026-05-12 | 11.86M shares derived: average of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | 12.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | 12.10M shares derived: average of 2 quarters · filed 2026-03-09 | 11.75M shares derived: average of 3 quarters · filed 2026-03-09 | 10.92M shares 10-K · filed 2026-03-09 | ||
| 2024-09-30 | 12.01M shares 10-Q · filed 2025-11-12 | 11.53M shares derived: average of 2 quarters · filed 2025-11-12 | 10.49M shares 10-Q · filed 2025-11-12 | 8.95M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 11.05M shares 10-Q · filed 2025-08-05 | 9.68M shares 10-Q · filed 2025-08-05 | 7.93M shares derived: average of 3 quarters · filed 2025-08-05 | 7.05M shares derived: average of 4 quarters · filed 2025-08-05 | ||
| 2024-03-31 | 8.31M shares 10-Q · filed 2025-05-06 | 6.37M shares derived: average of 2 quarters · filed 2025-05-06 | 5.72M shares derived: average of 3 quarters · filed 2025-05-06 | 5.36M shares derived: average of 4 quarters · filed 2025-05-06 | ||
| 2023-12-31 | 4.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 4.42M shares derived: average of 2 quarters · filed 2025-03-11 | 4.38M shares derived: average of 3 quarters · filed 2025-03-11 | 4.33M shares 10-K · filed 2025-03-11 | ||
| 2023-09-30 | 4.42M shares 10-Q · filed 2024-11-07 | 4.35M shares derived: average of 2 quarters · filed 2024-11-07 | 4.30M shares 10-Q · filed 2024-11-07 | 4.26M shares derived: average of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | 4.28M shares 10-Q · filed 2024-08-06 | 4.23M shares 10-Q · filed 2024-08-06 | 4.21M shares derived: average of 3 quarters · filed 2024-08-06 | 4.20M shares derived: average of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | 4.18M shares 10-Q · filed 2024-05-07 | 4.18M shares derived: average of 2 quarters · filed 2024-05-07 | 4.17M shares derived: average of 3 quarters · filed 2024-05-07 | 4.17M shares derived: average of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | 4.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 4.17M shares derived: average of 2 quarters · filed 2024-03-12 | 4.17M shares derived: average of 3 quarters · filed 2024-03-12 | 4.17M shares 10-K · filed 2024-03-12 | ||
| 2022-09-30 | 4.17M shares 10-Q · filed 2023-11-07 | 125.27M shares 10-Q · filed 2022-11-08 | 4.17M shares derived: average of 2 quarters · filed 2023-11-07 | 4.17M shares 10-Q · filed 2023-11-07 | 125.26M shares 10-Q · filed 2022-11-08 | -84.45M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 4.17M shares 10-Q · filed 2023-08-08 | 4.17M shares 10-Q · filed 2023-08-08 | -113.99M shares derived: average of 3 quarters · filed 2023-08-08 | -54.19M shares derived: average of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | 4.17M shares 10-Q · filed 2023-05-09 | -173.08M shares derived: average of 2 quarters · filed 2023-05-09 | -73.65M shares derived: average of 3 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -350.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -112.56M shares derived: average of 2 quarters · filed 2023-03-07 | 4.09M shares 10-K · filed 2023-03-07 | |||
| 2021-09-30 | 125.21M shares 10-Q · filed 2022-11-08 | 122.23M shares 10-Q · filed 2022-11-08 | ||||
| 2020-06-30 | 73.89M shares 10-Q/A · filed 2020-08-31 | 71.58M shares 10-Q/A · filed 2020-08-31 | ||||
| 2019-06-30 | 68.51M shares 10-Q/A · filed 2020-08-31 | 63.12M shares 10-Q/A · filed 2020-08-31 | ||||
| 2018-06-30 | 57.16M shares 10-Q · filed 2019-08-08 | 56.76M shares 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |